Press Releases

Press Releases

CAMBRIDGE, MA – December 22, 2011 – Quanterix Corporation, a company enabling a new generation of molecular diagnostic tests based on its revolutionary Single Molecule Array (SiMoA™) technology, has reported a method for detecting individual proteins within microfabricated polymer arrays produced…
LEXINGTON, Mass., January 22, 2013 – Quanterix Corporation announced today that Analytical Chemistry has published a ground-breaking study in which its Simoa technology was used to directly measure bacterial genomic DNA of S. aureus in both human blood and river water at sub-femtomolar…
Lexington, Mass. – February 20, 2014 – Quanterix Corporation, Quanterix Corporation, a leader in high definition diagnostics, delivering ultrasensitive single molecule measurement for the benefit of human health, today announced that it was one of the 33 recipients of the Massachusetts Life…
CHICAGO– December 18, 2014 Ten scientists are being honored as finalists for the 2015 SLAS Innovation Award, with the winner to be identified at the closing session of SLAS2015. The winner will receive a $10,000 cash prize along with having their name added to the prestigious list of previous…
LEXINGTON, MA – June 1, 2015 Quanterix Corporation, a leader in high definition diagnostics, delivering ultrasensitive single molecule measurement for the benefit of human health, today announced that it is launching a series of conferences focused on the incredible potential and impact of…
LEXINGTON, MA – October 6, 2015 Quanterix Corporation, a leader in high definition diagnostics, delivering ultrasensitive single molecule measurement for the benefit of human health, today announced the publication of a collaborative whitepaper that addresses concussion management, science, policy…
February 5, 2016
Quanterix announces that is participating in the NFL Health and Safety Update & Interactive Head Health Showcase at Super Bowl 50.
June 15, 2016
Frontage Laboratories, Inc., a Contract Research Organization based in Pennsylvania, New Jersey and China, announces that they are the first CRO to complete a GLP validation of the Simoa HD-1 Analyzer and software along with the interface to Watson LIMS.
January 9. 2017
Amended licensing agreement with long-term partner allows Quanterix to continue innovation and commercialization within its expanding fields
June 22, 2017
CEO and Chairman, Kevin Hrusovsky, will be hosting a webinar on the use of ultrasensitive biomarker assays to enable precision health, with a specialty focus on concussion and traumatic brain injury (TBI) detection and diagnostics.  Hrusovsky will be joined by Dr. Jessica Gill, Investigator at…